Regeneron Pharmaceuticals, Inc. Equity-NMS: REGN

$722.83 -0.84 (December 5, 2025)

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Previous close :$723.67
Open :$732.45
Today's high :$735
Today's low :$721.22
52W low :$475.1718
52W high :$796.5721
1Y :-3.1%
5Y :48.93%
EPS(TTM): :41.26
Shares O/S :103.28 M
Market cap :74.66 B

Compare with Other Stocks

Frequently Asked Questions

What is the share price of Regeneron Pharmaceuticals, Inc. today?

Regeneron Pharmaceuticals, Inc. (REGN) share price as of December 5, 2025, is $722.83. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Regeneron Pharmaceuticals, Inc.?

Yes, Indian Investors can invest in the Regeneron Pharmaceuticals, Inc. (REGN) Share by opening an international trading account with Angel One.

How can I purchase Regeneron Pharmaceuticals, Inc. shares in India?

Purchasing Regeneron Pharmaceuticals, Inc. (REGN) share from India can be done by:
  1. Directly: By opening an international trading account with Angel One. The process would include KYC verification.
    The account activation takes a few minutes to a few hours, after which you can start buying Regeneron Pharmaceuticals, Inc. (REGN) by making deposits in US dollars.
  2. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Regeneron Pharmaceuticals, Inc.?

Yes, you can purchase fractional shares of Regeneron Pharmaceuticals, Inc. (REGN) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Regeneron Pharmaceuticals, Inc.?

The market capitalization of Regeneron Pharmaceuticals, Inc. on December 5, 2025, is $74.66 B.

In which sector Regeneron Pharmaceuticals, Inc. belongs?

Regeneron Pharmaceuticals, Inc. operates in the Healthcare sector, specifically in the Biotechnology industry.

What documents are required to invest in Regeneron Pharmaceuticals, Inc. stocks?

In order to invest in Regeneron Pharmaceuticals, Inc. (REGN) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

About Regeneron Pharmaceuticals, Inc.

Regeneron Pharmaceuticals, Inc. is a fully integrated biotechnology company. The Company invents, develops, manufactures, and commercializes medicines for people with serious diseases. Its products and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. The Company is accelerating drug development using its proprietary technologies, such as VelociSuite, which produces optimized fully human antibodies and new classes of bispecific antibodies. VelociSuite consists of VelocImmune, VelociGene, VelociMouse, VelociMab, Veloci-Bi, VelociT, VelociHum, and other related technologies. Its marketed products include EYLEA (aflibercept); Dupixent (dupilumab); Libtayo (cemiplimab); Ordspono (odronextamab); Kevzara (sarilumab); Itepekimab; Linvoseltamab, and others.